Picture of BRAIN Biotech AG logo

BNN BRAIN Biotech AG Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for BRAIN Biotech AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
2024
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-9.02-4.68-6.34-8.11-11.1
Depreciation
Deferred Taxes
Non-Cash Items-0.998-4.82-3.07-1.35-2.76
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital1.291.343.640.1395.44
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-4.77-3.91-1.49-4.22-3.58
Capital Expenditures-2.86-1.26-6.08-2.64-1.73
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1.61-0.918-6.63.20.04
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4.47-2.18-12.70.562-1.69
Financing Cash Flow Items14.614.40-9.590.6
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities13.111.6-1.970.45927
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.785.6-16.1-3.0921.8